Intraoperative dynamic susceptibility contrast weighted magnetic resonance imaging (iDSC-MRI) - Technical considerations and feasibility

NeuroImage

Volumn 45, Issue 1, 2009, Pages 38-43

  Ulmer, Stephan ^a   Helle, Michael ^a   Jansen, Olav ^a   Mehdorn, H Maximilian ^a   Nabavi, Arya ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Brain tumor; DSC MRI; Intraoperative MRI; Perfusion

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; ARTIFACT; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN MAPPING; BRAIN PERFUSION; BRAIN SURGERY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; FEMALE; GLIOBLASTOMA; HUMAN; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; MALE; NEURONAVIGATION; NUCLEAR MAGNETIC RESONANCE SCANNER; PHANTOM; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

AGED; BRAIN NEOPLASMS; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; GADOLINIUM DTPA; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SURGERY, COMPUTER-ASSISTED; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TREATMENT OUTCOME;

EID: 60149089864     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2008.11.021     Document Type: Article

References (40)

1. Belliveau J.W., Rosen B.R., Kantor H.L., Rzedzian R.R., Kennedy D.N., McKinstry R.C., Vevea J.M., Cohen M.S., Pykett I.L., and Brady T.J. Functional cerebral imaging by susceptibility-contrast NMR. Magn. Reson. Med. 14 (1990) 538-546
2. Boxerman J.L., Schmainda K.M., and Weisskoff R.M. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am. J. Neuroradiol. 27 (2006) 859-867
3. Brix G., Semmler W., Port R., Schad L.R., Layer G., and Lorenz W.J. Pharmacokinetic parameters in CNS Gd.DTPA-enhanced MR imaging. J. Comput. Assist. Tomogr. 15 (1991) 621-628
4. Bullock P.R., Mansfield P., Gowland P., Worthington B.S., and Firth J.L. Dynamic imaging of contrast enhancement in brain tumors. Magn. Reson. Med. 19 (1991) 293-298
5. Caseiras G.B., Thornton J.S., Yousry T., Benton C., Rees J., Waldman A.D., and Jäger H.R. Inclusion or exclusion of intratumoral vessels in relative cerebral blood volume characterization in low-grade gliomas: does it make a difference?. AJNR Am. J. Neuroradiol. 29 6 (2008) 1140-1141
6. Conturo T.E., Akbudak E., Kotys M.S., Chen M.L., Chun S.J., Hsu R.M., Sweeney C.C., and Markham J. Arterial input functions for dynamic susceptibility contrast MRI: requirements and signal options. J. Magn. Reson. Imaging 22 (2005) 697-703
7. Covarrubias D.J., Rosen B.R., and Lev M.H. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 9 (2004) 528-537
8. Edelman R.R., Mattle H.P., Atkinson D.J., Hill T., Finn J.P., Mayman C., Ronthal M., Hoogewoud H.M., and Kleefield J. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. Radiology 176 (1990) 211-220
9. Emblem K.E., Nedregaard B., Nome T., Due-Tonnessen P., Hald J.K., Scheie D., Borota O.C., Cvancarova M., and Bjornerud A. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 247 (2008) 808-817
10. Donahue K.M., Weisskoff R.M., Parmalee D.J., Callahan R.J., Wilkinson R.A., Mandeville J.B., and Rosen B.R. Dynamic Gd-DTPA enhancement MRI measurement of tissue cell volume fraction. Magn. Reson. Med. 34 (1995) 423-432
11. Donahue K.M., Krouwer H.G., Rand S.D., Pathak A.P., Marszalkowski C.S., Censky S.C., and Prost R.W. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients. Magn. Reson. Med. 43 (2000) 845-853
12. Galanis E., Buckner J.C., Maurer M.J., Sykora R., Castillo R., Ballman K.V., and Erickson B.J. Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods. Neuro. Oncol. 8 (2006) 156-165
13. Hanson M., Glantz M., Hoffman J., Friedman A.H., Burger P.C., Schold S.C., and Coleman R.E. FDG-PET in the selection of brain lesions for biopsy. J. Comput. Assist. Tomogr. 15 (1991) 796-801
14. Haroon H.A., Patankar T.F., Zhu X.P., Li K.L., Thacker N.A., Scott M.J., and Jackson A. Comparison of cerebral blood volume maps generated from T2* and T1 weighted MRI data in intra-axial cerebral tumours. Br. J. Radiol. 80 (2007) 161-168
15. Hartmann M., Heiland S., Harting I., Tronnier V.M., Sommer C., Ludwig R., and Sartor K. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci. Lett. 338 (2003) 119-122
16. Knauth M., Aras N., Wirtz C.R., Dorfler A., Engelhorn T., and Sartor K. Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging. AJNR AM. J. Neuroradiol. 20 (1999) 1547-1553
17. Knopp E.A., Cha S., Johnson G., Mazumdar A., Golfinos J.G., Zagzag D., Miller D.C., Kelly P.J., and Kricheff I.I. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211 (1999) 791-798
18. Law M., Cha S., Knopp E.A., Johnson G., Arnett J., and Litt A.W. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222 (2002) 715-721
19. Law M., Oh S., Babb J.S., Wnag E., Inglese M., Zagzag D., Knopp E.A., and Johnson G. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging-prediction of patient clinical response. Radiology 238 (2006) 658-667
20. Lev M.L., Ozsunar Y., Henson J.W., Rasheed A.A., Barest G.D., Harsh IV G.R., Fitzek M.M., Chiocca E.A., Rabinov J.D., Csavoy A.N., Rosen B.R., Hochberg F.H., Schaefer P.W., and Gonzalez R.G. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared to conventional contrast enhanced MRI: confounding effect of elevated relative cerebral blood volume of oligodendrogliomas. AJNR Am. J. Neuroradiol. 25 (2004) 214-221
21. Li K.L., Zhu X.P., Waterton J., and Jackson A. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J. Magn. Reson. Imaging 12 (2000) 347-357
22. Ludemann L., Grieger W., Wurm R., Budzisch M., Hamm B., and Zimmer C. Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur. Radiol. 11 (2001) 1231-1241
23. Ludemann, L., Warmuth, C., Plotkin, M., Forschler, A., Gutberlet, M., Wust, P., Amthauer, H., in press. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H215O positron emission tomography. Eur. J. Radiol. doi:10.1016/j.jrad.2008.02.12.
24. Nabavi A., Black P.M., Gering D.T., Westin C.F., Mehta V., Pergolizzi Jr. R.S., Ferrant M., Warfield S.K., Hata N., Schwartz R.B., Wells III W.M., Kikinis R., and Jolesz F.A. Serial intraoperative magnetic resonance imaging of brain shift. Neurosurgery 48 (2001) 787-797
25. Ogawa S., Menon R.S., Tank D.W., Kim S.-G., Merkle H., Ellermann J.M., and Ugurbil K. Functional brain mapping byblood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with biophysical model. Biophys. J. 64 (1993) 803-812
26. Ostergaard L. Principles of cerebral perfusion imaging by bolus tracking. J. Magn. Reson. Imaging 22 (2005) 710-717
27. Parker G.J., Suckling J., Tanner S.F., Padhani A.R., Revell P.B., Husband J.E., and Leach M.O. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J. Magn. Reson. Imaging 7 (1997) 564-574
28. Phelps M.E., Huang S.C., Hoffman E.J., Selin C., Sokoloff L., and Kuhl D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann. Neurol. 6 (1979) 371-388
29. Provenzale J.M., Wang G.R., Brenner T., Petrella J.R., and Sorensen A.G. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am. J. Roentgenol. 178 (2002) 711-716
30. Rosen B.R., Belliveau J.W., Vevea J.M., and Brady T.J. Perfusion imaging with NMR contrast agents. Magn. Reson. Med. 14 (1990) 249-265
31. Sorensen A.G., Copen W.A., Ostergaard L., Buonanno F.S., Gonzalez R.G., Rordorf G., Rosen B.R., Schwamm L.H., Weisskoff R.M., and Koroshert W.J. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean transit time. Radiology 210 (1999) 519-527
32. Sorensen A.G., Copen W.A., Ostergaard L., Buonanno F.S., Gonzalez R.G., Rordorf G., Rosen B.R., Schwamm L.H., Weisskoff R.M., and Koroshetz W.J. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 210 (1999) 519-527
33. Stummer W., Reulen H.J., Meinel T., Pichlmeier U., Schumacher W., Tonn J.C., Rohde V., Oppel F., Turowski B., Woiciechowsky C., Franz K., Pietsch T., and ALA-Glioma Study group. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62 (2008) 564-576
34. Subramanyam R., Alpert N.M., Hoop Jr. B., Brownell G.L., and Taveras J.M. A model for regional cerebral oxygen distribution during continuous inhalation of 15O2, C15O, and C15O2. J. Nucl. Med. 19 (1978) 48-53
35. Sugahara T., Korogi Y., Kochi M., Ikushima I., Hirai T., Okuda T., Shigematsu Y., Liang L., Ge Y., Ushio Y., and Takahashi M. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR. Am. J. Roentgenol. 171 (1998) 1479-1486
36. Sugahara T., Korogi Y., Tomiguchi S., Shigematsu Y., Ikushima I., Kira T., Liang L., Ushio Y., and Takahashi M. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am. J. Neuroradiol. 21 (2000) 901-909
37. Ulmer S., Liess C., Kesari S., Otto N., Straube T., and Jansen O. Use of dynamic susceptibility-contrast MRI (DSC-MRI) to assess perfusion changes in the ipsilateral brain parenchyma from glioblastoma. J. Neurooncol. 91 2 (2009) 213-220
38. Villringer A., Rosen B.R., Belliveau J.W., Ackerman J.L., Lauffer R.B., Buxton R.B., Chao Y.S., Wedeen V.J., and Brady T.J. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn. Reson. Med. 6 (1988) 164-174
39. Werner R., Norris D.G., Alfke K., Mehdorn H.M., and Jansen O. Continuous artery-selective spin labeling (CASSL). Magn. Reson. Med. 53 (2005) 1006-1012
40. Worthington B.S., Bullock P.R., Stehling M., Gowland P., Firth J.L., and Mansfield P. Clinical experience with contrast enhanced echo-planar imaging of the brain. Magn. Reson. Med. 22 (1991) 255-258